Moscow [Russia], April 2 (ANI): Russian Health Ministry has registered the nasal version of Sputnik V, the world's first nasal vaccine against COVID-19.

Moscow [Russia], November 24 (ANI): Russia's Health Ministry will register the Sputnik vaccine for children aged 12-17 on Wednesday, with shots expected to be available at the end of December.

Buenos Aires [Argentina], November 1 (ANI/Sputnik): A study conducted by the health ministry of the city of Buenos Aires, Argentina, showed high efficacy of the Russian-made COVID-19 vaccine Sputnik V in protecting people aged 60 and older, the Russian Direct Investment Fund (RDIF) said on Monday.

Hyderabad Oct 29 PTI Dr Reddys Laboratories Ltd is expected to submit Phase 3 trials data of single dose Russian COVID-19 vaccine Sputnik Light to the Indian drug regulator next month even as the city-based firm is getting ready to conduct trials of the jab in 2 to 18 year old children in two cohorts Deepak Sapra CEO API and Services Dr Reddys said the drug maker is in discussions with the Drug Controller General of India to conduct trials on introducing Sputnik V as booster dose He also said Dr Reddys is trying to engage in discussions with the Centre for Sputnik V Government supplies even as the company sees softness in the off take of the vaccine in the private sector As far as Sputnik Light is concerned we are in the midst of our clinical trials and we expect that we are able to update post our submission to the DCGI in the month of November As far as Sputnik as a booster dose is concerned we have finalised our protocol We are in discussions with DCGI for initiating the trials for Sputnik booster dose Sapra said in a virtual press conference Addition to the servicing the Indian requirements Dr Reddys is in discussions with its partners to take the jab to other countries notably in Asia-Pacific Africa and Latin America he further said We are seeing softness in the off take of the vaccine in the private sector in India the official said According to the recommendations of the SEC meeting held in August last Dr Reddys which has tied up with Russian Direct Investment Fund to market the jab in India presented updated safety immunogenicity and efficacy data of Phase III clinical trial of Sputnik Light vaccine conducted in Russia along with the proposal to conduct the clinical trial in India The trials of Sputnik as booster dose and paediatric dose are being conducted by RDIF outside India Sapra explained adding that the trials in India may take off in November PTI GDK ROH ROH

Moscow [Russia], October 8 (ANI): Russian Direct Investment Fund on Thursday said that coronavirus vaccine Sputnik Light has proven to be an ideal booster for other vaccines and is ready to fight the COVID-19 globally.

Moscow [Russia], September 24 (ANI): The Russian Direct Investment Fund (RDIF) on Friday announced the Russian single-component Sputnik Light vaccine against coronavirus has been approved by the Egyptian Drug Authority (EDA).

Moscow [Russia], August 25 (ANI): Indonesia has approved the use of Russia's Sputnik COVID-19 vaccine for emergency use in the country.